Philmans Pharm,, The German Patient Roundtable

Est. 1977

Isodiol and Canadian Zeolite Sign Agreement for R&D of Cannabinoid-Infused Products

CARLSBAD, CA / ACCESSWIRE / December 27, 2016 / Isodiol, the Southern California-based cannabinoid innovator, is proud to announce that it has reached an agreement with Vancouver, British Columbia, Canadian Zeolite Corp. (the “Company”) (TSX-V: CNZ) (OTCQB: CNZCF) (FSE: ZEON) to research and develop cannabinoid-infused Zeolite products. The initial products to be developed are intended for human and animal consumption.

Zeolites are microporous, aluminosilicate minerals commonly used as commercial adsorbents and catalysts. The term zeolite was originally coined in 1756 by Swedish mineralogist Axel Fredrik Cronstedt, who observed that upon rapidly heating the material stilbite, it produced large amounts of steam from water that had been adsorbed by the material. Based on this, he called the material zeolite, from the Greek word meaning “to boil” and “stone”. Zeolites occur naturally but are also produced industrially on a large scale.

The Canadian Zeolite products developed with Isodiol will be
nano-amplified for immediate bioavailability then combined with cannabinoids and other adaptogenic herbs. The first products will consist of detoxifying, anti-aging products for oral consumption.

As with all of Isodiol’s cannabinoid products, all Zeolite products will be laboratory tested for purity prior and documented with certificates of analysis with each product run.

Isodiol’s Chief Operating Officer, Troy Nihart, stated, “Isodiol is looking forward to introducing these new products to the marketplace. Zeolite, as an additive, has tremendous potential especially with its detoxification properties. We feel there is an undiscovered zeolite market which we can begin to develop and are very excited to begin a partnership with Canadian Zeolite.”

Ray Paquette, Chief Executive Officer for Canadian Zeolite stated, “We are excited to be working with Isodiol who is at the forefront of developing and marketing CBD products. We are excited to implement our natural zeolite into Isodiol’s already successful product lines which will bring immediate value to our shareholders.”

Correction to Prior Release: Isodiol’s R&D will focus on human and pet-grade zeolite-infused anti-aging products intended for detoxification.

Media Contact:

Denise Mahaffey

About Canadian Zeolite:

Canadian Zeolite Corp. is an environmentally friendly Green Tech business well suited to today’s economic environment. The Company is operating and has a competitive advantage in the world of zeolites given the products has been tested, applied and exceeds the standards of specific markets. The Company is working with dedicated global advisors recognized as leaders in zeolite use.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Some statements in this news release contain forward-looking information. These statements include, but are not limited to, statements with respect to future expenditures. These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include, among others, the ability to complete contemplated work programs and the timing and amount of expenditures. Canadian Zeolite does not assume the obligation to update any forward-looking statement.

About Isodiol:

Isodiol and its team of collaborators are a group of companies that together, grow & harvest hemp on an industrial scale, and then process it to extract the non-psychoactive cannabinoids to the highest available purity for worldwide distribution. By utilizing one of the world’s largest hemp farms, Isodiol and its partners are the choice for industrial volumes of high-grade, non-psychoactive cannabinoids. Pharmaceutical, nutraceutical and cosmetic companies worldwide have gained market share due to our products. For more information, visit To follow Isodiol online, visit Facebook, Instagram, and Twitter.


Over the last 4 decades I have been involved in the fight for patient rights in America, and now here in Germany. During my career I have served as a Board of Director for the World Trade Center San Diego and as a Lead Consultant for Deutsche Telekom's Executive Board, Co-Founded the San Diego Software Council and the Dayton Human Trafficking Accords and was Director of LawInfo's Lead Council Program. Previously I was a C-Level Business Development Executive in the technology sector, but also involved with the cannabis industry since 1977. More recently I have been fulltime in the legal medical marijuana industry here in Europe, helping international companies navigate the biggest potential market in the world. This website is light on details due to confidentiality issues with clients but be rest assured I am knowledgeable, professional and with street cred in the industry that can immediately assist your growth in some way. Consulting Services: Sales and Business Development Assist with Strategic Direction Professionally represent your firm Special Projects management Licensing and compliance Sales and Distribution networks Qualify potential partners I am your resource on the ground in Europe, contact me directly to schedule an initial discussion on the German Cannabis-as-Medicine market. Thank you, Philip J. Cenedella IV Call +1.888.206.3264 USA + GERMANY Skype: philip.j.cenedella eMail: LinkedIN:

Comments are closed.